Atlas Trials

Investigating the Influence of Oral Semaglutide on Pharmacokinetics of Metformin and Digoxin in Healthy Subjects

Clinical trial NCT02249910 · COMPLETED

Trial details

NCT number
NCT02249910
Sponsor
Novo Nordisk A/S
Status
COMPLETED
Phase
Phase 1
Study type
INTERVENTIONAL
DiabetesHealthy
Start date
2014-09-18
Primary completion
2015-03-06
Enrollment
32

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.